Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Occupation and risk of lymphoma: a multicentre prospective cohort study (EPIC).

Neasham D, Sifi A, Nielsen KR, Overvad K, Raaschou-Nielsen O, Tjønneland A, Barricarte A, González CA, Navarro C, Rodriguez Suarez L, Travis RC, Key T, Linseisen J, Kaaks R, Crosignani P, Berrino F, Rosso S, Mattiello A, Vermeulen RC, Bueno-de-Mesquita HB, Berglund G, Manjer J, Zackrisson S, Hallmans G, Malmer B, Bingham S, Khaw KT, Bergmann MM, Boeing H, Trichopoulou A, Masala G, Tumino R, Lund E, Slimani N, Ferrari P, Boffetta P, Vineis P, Riboli E.

Occup Environ Med. 2011 Jan;68(1):77-81. doi: 10.1136/oem.2009.048173. Epub 2010 Sep 30. Erratum in: Occup Environ Med. 2011 Jul;68(7):550.

PMID:
20884795
2.

Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA).

Osorio A, Milne RL, Pita G, Peterlongo P, Heikkinen T, Simard J, Chenevix-Trench G, Spurdle AB, Beesley J, Chen X, Healey S; KConFab, Neuhausen SL, Ding YC, Couch FJ, Wang X, Lindor N, Manoukian S, Barile M, Viel A, Tizzoni L, Szabo CI, Foretova L, Zikan M, Claes K, Greene MH, Mai P, Rennert G, Lejbkowicz F, Barnett-Griness O, Andrulis IL, Ozcelik H, Weerasooriya N; OCGN, Gerdes AM, Thomassen M, Cruger DG, Caligo MA, Friedman E, Kaufman B, Laitman Y, Cohen S, Kontorovich T, Gershoni-Baruch R, Dagan E, Jernström H, Askmalm MS, Arver B, Malmer B; SWE-BRCA, Domchek SM, Nathanson KL, Brunet J, Ramón Y Cajal T, Yannoukakos D, Hamann U; HEBON, Hogervorst FB, Verhoef S, Gómez García EB, Wijnen JT, van den Ouweland A; EMBRACE, Easton DF, Peock S, Cook M, Oliver CT, Frost D, Luccarini C, Evans DG, Lalloo F, Eeles R, Pichert G, Cook J, Hodgson S, Morrison PJ, Douglas F, Godwin AK; GEMO, Sinilnikova OM, Barjhoux L, Stoppa-Lyonnet D, Moncoutier V, Giraud S, Cassini C, Olivier-Faivre L, Révillion F, Peyrat JP, Muller D, Fricker JP, Lynch HT, John EM, Buys S, Daly M, Hopper JL, Terry MB, Miron A, Yassin Y, Goldgar D; Breast Cancer Family Registry, Singer CF, Gschwantler-Kaulich D, Pfeiler G, Spiess AC, Hansen TV, Johannsson OT, Kirchhoff T, Offit K, Kosarin K, Piedmonte M, Rodriguez GC, Wakeley K, Boggess JF, Basil J, Schwartz PE, Blank SV, Toland AE, Montagna M, Casella C, Imyanitov EN, Allavena A, Schmutzler RK, Versmold B, Engel C, Meindl A, Ditsch N, Arnold N, Niederacher D, Deissler H, Fiebig B, Varon-Mateeva R, Schaefer D, Froster UG, Caldes T, de la Hoya M, McGuffog L, Antoniou AC, Nevanlinna H, Radice P, Benítez J; CMBA.

Br J Cancer. 2009 Dec 15;101(12):2048-54. doi: 10.1038/sj.bjc.6605416. Epub 2009 Nov 17.

3.

Genetic variants in association studies--review of strengths and weaknesses in study design and current knowledge of impact on cancer risk.

Andersson U, McKean-Cowdin R, Hjalmars U, Malmer B.

Acta Oncol. 2009;48(7):948-54. Review.

PMID:
19863254
4.

Pre-emptive treatment with rituximab of molecular relapse after autologous stem cell transplantation in mantle cell lymphoma.

Andersen NS, Pedersen LB, Laurell A, Elonen E, Kolstad A, Boesen AM, Pedersen LM, Lauritzsen GF, Ekanger R, Nilsson-Ehle H, Nordström M, Fredén S, Jerkeman M, Eriksson M, Väärt J, Malmer B, Geisler CH.

J Clin Oncol. 2009 Sep 10;27(26):4365-70. doi: 10.1200/JCO.2008.21.3116. Epub 2009 Aug 3.

PMID:
19652064
5.

A case for the worldwide collection of primary benign brain tumors.

McCarthy BJ, Schellinger KA, Propp JM, Kruchko C, Malmer B.

Neuroepidemiology. 2009;33(3):268-75. doi: 10.1159/000230808. Epub 2009 Jul 31. Review.

6.

Tumor-associated epilepsy and glioma: are there common genetic pathways?

Berntsson SG, Malmer B, Bondy ML, Qu M, Smits A.

Acta Oncol. 2009;48(7):955-63. doi: 10.1080/02841860903104145. Review.

7.

Level of education and the risk of lymphoma in the European prospective investigation into cancer and nutrition.

Hermann S, Rohrmann S, Linseisen J, Nieters A, Khan A, Gallo V, Overvad K, Tjønneland A, Raaschou-Nielsen O, Bergmann MM, Boeing H, Becker N, Kaaks R, Bueno-de-Mesquita HB, May AM, Vermeulen RC, Bingham S, Khaw KT, Key TJ, Travis RC, Trichopoulou A, Georgila C, Triantafylou D, Celentano E, Krogh V, Masala G, Tumino R, Agudo A, Altzibar JM, Ardanaz E, Martínez-García C, Suárez MV, Tormo MJ, Braaten T, Lund E, Manjer J, Zackrisson S, Hallmans G, Malmer B, Boffetta P, Brennan P, Slimani N, Vineis P, Riboli E.

J Cancer Res Clin Oncol. 2010 Jan;136(1):71-7. doi: 10.1007/s00432-009-0638-9.

PMID:
19582474
8.

Genome-wide association study identifies five susceptibility loci for glioma.

Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, Malmer B, Simon M, Marie Y, Boisselier B, Delattre JY, Hoang-Xuan K, El Hallani S, Idbaih A, Zelenika D, Andersson U, Henriksson R, Bergenheim AT, Feychting M, Lönn S, Ahlbom A, Schramm J, Linnebank M, Hemminki K, Kumar R, Hepworth SJ, Price A, Armstrong G, Liu Y, Gu X, Yu R, Lau C, Schoemaker M, Muir K, Swerdlow A, Lathrop M, Bondy M, Houlston RS.

Nat Genet. 2009 Aug;41(8):899-904. doi: 10.1038/ng.407. Epub 2009 Jul 5.

9.

Co-incidental increase in gene copy number of ERBB2 and LRIG1 in breast cancer.

Ljuslinder I, Golovleva I, Henriksson R, Grankvist K, Malmer B, Hedman H.

Breast Cancer Res. 2009;11(3):403. doi: 10.1186/bcr2248. Epub 2009 May 12. No abstract available.

10.

ErbB 1-4 expression alterations in primary colorectal cancers and their corresponding metastases.

Ljuslinder I, Malmer B, Isaksson-Mettävainio M, Oberg A, Henriksson R, Stenling R, Palmqvist R.

Anticancer Res. 2009 May;29(5):1489-94.

11.

MNS16A minisatellite genotypes in relation to risk of glioma and meningioma and to glioblastoma outcome.

Andersson U, Osterman P, Sjöström S, Johansen C, Henriksson R, Brännström T, Broholm H, Christensen HC, Ahlbom A, Auvinen A, Feychting M, Lönn S, Kiuru A, Swerdlow A, Schoemaker M, Roos G, Malmer B.

Int J Cancer. 2009 Aug 15;125(4):968-72. doi: 10.1002/ijc.24363.

12.

Long-term risk of cardiovascular disease in Hodgkin lymphoma survivors--retrospective cohort analyses and a concept for prospective intervention.

Andersson A, Näslund U, Tavelin B, Enblad G, Gustavsson A, Malmer B.

Int J Cancer. 2009 Apr 15;124(8):1914-7. doi: 10.1002/ijc.24147.

13.

Telemedicine as a tool for sharing competence in paediatric radiotherapy: implementation and initial experiences from a Swedish project.

Kristensen I, Lindh J, Nilsson P, Agrup M, Bergström P, Björk-Eriksson T, Engellau J, Hjelm-Skog AL, Malmer B, Martinsson U, Karlsson M.

Acta Oncol. 2009;48(1):146-52. doi: 10.1080/02841860802409520. No abstract available.

PMID:
18846448
14.

Anthropometric characteristics and non-Hodgkin's lymphoma and multiple myeloma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC).

Britton JA, Khan AE, Rohrmann S, Becker N, Linseisen J, Nieters A, Kaaks R, Tjønneland A, Halkjaer J, Severinsen MT, Overvad K, Pischon T, Boeing H, Trichopoulou A, Kalapothaki V, Trichopoulos D, Mattiello A, Tagliabue G, Sacerdote C, Peeters PH, Bueno-de-Mesquita HB, Ardanaz E, Navarro C, Jakszyn P, Altzibar JM, Hallmans G, Malmer B, Berglund G, Manjer J, Allen N, Key T, Bingham S, Besson H, Ferrari P, Jenab M, Boffetta P, Vineis P, Riboli E.

Haematologica. 2008 Nov;93(11):1666-77. doi: 10.3324/haematol.13078. Epub 2008 Oct 2.

15.

CASP8 D302H and meningioma risk: an analysis of five case-control series.

Bethke L, Sullivan K, Webb E, Murray A, Schoemaker M, Auvinen A, Kiuru A, Salminen T, Johansen C, Christensen HC, Muir K, McKinney P, Hepworth S, Dimitropoulou P, Lophatananon A, Feychting M, Lönn S, Ahlbom A, Malmer B, Henriksson R, Swerdlow A, Houlston R.

Cancer Lett. 2009 Jan 18;273(2):312-5. doi: 10.1016/j.canlet.2008.08.010. Epub 2008 Sep 26.

PMID:
18823701
16.

Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium.

Bondy ML, Scheurer ME, Malmer B, Barnholtz-Sloan JS, Davis FG, Il'yasova D, Kruchko C, McCarthy BJ, Rajaraman P, Schwartzbaum JA, Sadetzki S, Schlehofer B, Tihan T, Wiemels JL, Wrensch M, Buffler PA; Brain Tumor Epidemiology Consortium.

Cancer. 2008 Oct 1;113(7 Suppl):1953-68. doi: 10.1002/cncr.23741. Review.

17.

Functional polymorphisms in folate metabolism genes influence the risk of meningioma and glioma.

Bethke L, Webb E, Murray A, Schoemaker M, Feychting M, Lönn S, Ahlbom A, Malmer B, Henriksson R, Auvinen A, Kiuru A, Salminen T, Johansen C, Christensen HC, Muir K, McKinney P, Hepworth S, Dimitropoulou P, Lophatananon A, Swerdlow A, Houlston R.

Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1195-202. doi: 10.1158/1055-9965.EPI-07-2733.

18.

The common D302H variant of CASP8 is associated with risk of glioma.

Bethke L, Sullivan K, Webb E, Murray A, Schoemaker M, Auvinen A, Kiuru A, Salminen T, Johansen C, Christensen HC, Muir K, McKinney P, Hepworth S, Dimitropoulou P, Lophatananon A, Feychting M, Lönn S, Ahlbom A, Malmer B, Henriksson R, Swerdlow A, Houlston R.

Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):987-9. doi: 10.1158/1055-9965.EPI-07-2807.

19.

Issues of diagnostic review in brain tumor studies: from the Brain Tumor Epidemiology Consortium.

Davis FG, Malmer BS, Aldape K, Barnholtz-Sloan JS, Bondy ML, Brännström T, Bruner JM, Burger PC, Collins VP, Inskip PD, Kruchko C, McCarthy BJ, McLendon RE, Sadetzki S, Tihan T, Wrensch MR, Buffler PA.

Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):484-9. doi: 10.1158/1055-9965.EPI-07-0725.

20.

XRCC1 and XRCC3 variants and risk of glioma and meningioma.

Kiuru A, Lindholm C, Heinävaara S, Ilus T, Jokinen P, Haapasalo H, Salminen T, Christensen HC, Feychting M, Johansen C, Lönn S, Malmer B, Schoemaker MJ, Swerdlow AJ, Auvinen A.

J Neurooncol. 2008 Jun;88(2):135-42. doi: 10.1007/s11060-008-9556-y.

PMID:
18330515
21.

Comprehensive analysis of DNA repair gene variants and risk of meningioma.

Bethke L, Murray A, Webb E, Schoemaker M, Muir K, McKinney P, Hepworth S, Dimitropoulou P, Lophatananon A, Feychting M, Lönn S, Ahlbom A, Malmer B, Henriksson R, Auvinen A, Kiuru A, Salminen T, Johansen C, Christensen HC, Kosteljanetz M, Swerdlow A, Houlston R.

J Natl Cancer Inst. 2008 Feb 20;100(4):270-6. doi: 10.1093/jnci/djn004. Epub 2008 Feb 12.

PMID:
18270339
22.

Family history of cancer as a risk factor for second malignancies after Hodgkin's lymphoma.

Andersson A, Enblad G, Tavelin B, Björkholm M, Linderoth J, Lagerlöf I, Merup M, Sender M, Malmer B.

Br J Cancer. 2008 Mar 11;98(5):1001-5. doi: 10.1038/sj.bjc.6604244. Epub 2008 Feb 12.

23.

Comprehensive analysis of the role of DNA repair gene polymorphisms on risk of glioma.

Bethke L, Webb E, Murray A, Schoemaker M, Johansen C, Christensen HC, Muir K, McKinney P, Hepworth S, Dimitropoulou P, Lophatananon A, Feychting M, Lönn S, Ahlbom A, Malmer B, Henriksson R, Auvinen A, Kiuru A, Salminen T, Swerdlow A, Houlston R.

Hum Mol Genet. 2008 Mar 15;17(6):800-5. Epub 2007 Nov 29.

PMID:
18048407
24.

Aggregation of cancer in first-degree relatives of patients with glioma.

Scheurer ME, Etzel CJ, Liu M, El-Zein R, Airewele GE, Malmer B, Aldape KD, Weinberg JS, Yung WK, Bondy ML.

Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2491-5.

25.

An international case-control study of interleukin-4Ralpha, interleukin-13, and cyclooxygenase-2 polymorphisms and glioblastoma risk.

Schwartzbaum JA, Ahlbom A, Lönn S, Malmer B, Wigertz A, Auvinen A, Brookes AJ, Collatz Christensen H, Henriksson R, Johansen C, Salminen T, Schoemaker MJ, Swerdlow AJ, Debinski W, Feychting M.

Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2448-54.

26.

Second primary tumors following a diagnosis of meningioma in Sweden, 1958-1997.

Davis F, Tavelin B, Grutsch J, Malmer B.

Neuroepidemiology. 2007;29(1-2):101-6. Epub 2007 Oct 16.

PMID:
17940341
27.

Treatment schedule is of importance when gefitinib is combined with irradiation of glioma and endothelial cells in vitro.

Andersson U, Johansson D, Behnam-Motlagh P, Johansson M, Malmer B.

Acta Oncol. 2007;46(7):951-60.

PMID:
17917826
28.

GLIOGENE an International Consortium to Understand Familial Glioma.

Malmer B, Adatto P, Armstrong G, Barnholtz-Sloan J, Bernstein JL, Claus E, Davis F, Houlston R, Il'yasova D, Jenkins R, Johansen C, Lai R, Lau C, McCarthy B, Nielsen H, Olson SH, Sadetzki S, Shete S, Wiklund F, Wrensch M, Yang P, Bondy M.

Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1730-4. Review.

29.

LRIG1 expression in colorectal cancer.

Ljuslinder I, Golovleva I, Palmqvist R, Oberg A, Stenling R, Jonsson Y, Hedman H, Henriksson R, Malmer B.

Acta Oncol. 2007;46(8):1118-22.

PMID:
17851870
30.

An international case-control study of glutathione transferase and functionally related polymorphisms and risk of primary adult brain tumors.

Schwartzbaum JA, Ahlbom A, Lönn S, Warholm M, Rannug A, Auvinen A, Christensen HC, Henriksson R, Johansen C, Lindholm C, Malmer B, Salminen T, Schoemaker MJ, Swerdlow AJ, Feychting M.

Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):559-65.

31.

The emergence of networks in human genome epidemiology: challenges and opportunities.

Seminara D, Khoury MJ, O'Brien TR, Manolio T, Gwinn ML, Little J, Higgins JP, Bernstein JL, Boffetta P, Bondy M, Bray MS, Brenchley PE, Buffler PA, Casas JP, Chokkalingam AP, Danesh J, Davey Smith G, Dolan S, Duncan R, Gruis NA, Hashibe M, Hunter D, Jarvelin MR, Malmer B, Maraganore DM, Newton-Bishop JA, Riboli E, Salanti G, Taioli E, Timpson N, Uitterlinden AG, Vineis P, Wareham N, Winn DM, Zimmern R, Ioannidis JP; Human Genome Epidemiology Network; Network of Investigator Networks.

Epidemiology. 2007 Jan;18(1):1-8. No abstract available.

PMID:
17179752
32.

Genetic variation in p53 and ATM haplotypes and risk of glioma and meningioma.

Malmer BS, Feychting M, Lönn S, Lindström S, Grönberg H, Ahlbom A, Schwartzbaum J, Auvinen A, Collatz-Christensen H, Johansen C, Kiuru A, Mudie N, Salminen T, Schoemaker MJ, Swerdlow AJ, Henriksson R.

J Neurooncol. 2007 May;82(3):229-37. Epub 2006 Dec 7.

PMID:
17151932
33.
34.

Estrogen receptor beta polymorphism is associated with prostate cancer risk.

Thellenberg-Karlsson C, Lindström S, Malmer B, Wiklund F, Augustsson-Bälter K, Adami HO, Stattin P, Nilsson M, Dahlman-Wright K, Gustafsson JA, Grönberg H.

Clin Cancer Res. 2006 Mar 15;12(6):1936-41.

35.

A road map for efficient and reliable human genome epidemiology.

Ioannidis JP, Gwinn M, Little J, Higgins JP, Bernstein JL, Boffetta P, Bondy M, Bray MS, Brenchley PE, Buffler PA, Casas JP, Chokkalingam A, Danesh J, Smith GD, Dolan S, Duncan R, Gruis NA, Hartge P, Hashibe M, Hunter DJ, Jarvelin MR, Malmer B, Maraganore DM, Newton-Bishop JA, O'Brien TR, Petersen G, Riboli E, Salanti G, Seminara D, Smeeth L, Taioli E, Timpson N, Uitterlinden AG, Vineis P, Wareham N, Winn DM, Zimmern R, Khoury MJ; Human Genome Epidemiology Network and the Network of Investigator Networks.

Nat Genet. 2006 Jan;38(1):3-5.

PMID:
16468121
36.

p53 Genotypes and risk of glioma and meningioma.

Malmer B, Feychting M, Lönn S, Ahlbom A, Henriksson R.

Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2220-3.

37.

Increased copy number at 3p14 in breast cancer.

Ljuslinder I, Malmer B, Golovleva I, Thomasson M, Grankvist K, Höckenström T, Emdin S, Jonsson Y, Hedman H, Henriksson R.

Breast Cancer Res. 2005;7(5):R719-27. Epub 2005 Jul 6.

38.

Polymorphisms associated with asthma are inversely related to glioblastoma multiforme.

Schwartzbaum J, Ahlbom A, Malmer B, Lönn S, Brookes AJ, Doss H, Debinski W, Henriksson R, Feychting M.

Cancer Res. 2005 Jul 15;65(14):6459-65.

39.

Homozygosity mapping of familial glioma in Northern Sweden.

Malmer B, Haraldsson S, Einarsdottir E, Lindgren P, Holmberg D.

Acta Oncol. 2005;44(2):114-9.

PMID:
15788289
40.

Prior hospitalization for epilepsy, diabetes, and stroke and subsequent glioma and meningioma risk.

Schwartzbaum J, Jonsson F, Ahlbom A, Preston-Martin S, Malmer B, Lönn S, Söderberg K, Feychting M.

Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):643-50.

41.

Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas.

Andersson U, Guo D, Malmer B, Bergenheim AT, Brännström T, Hedman H, Henriksson R.

Acta Neuropathol. 2004 Aug;108(2):135-42. Epub 2004 May 18.

PMID:
15148612
42.

Heterogeneity in the expression of markers for drug resistance in brain tumors.

Andersson U, Malmer B, Bergenheim AT, Brännström T, Henriksson R.

Clin Neuropathol. 2004 Jan-Feb;23(1):21-7.

PMID:
14986930
44.

Reproductive factors have low impact on the risk of different primary brain tumours in offspring.

Mogren I, Malmer B, Tavelin B, Damber L.

Neuroepidemiology. 2003 Jul-Aug;22(4):249-54.

PMID:
12792146
45.

Second primary cancers in men with prostate cancer: an increased risk of male breast cancer.

Thellenberg C, Malmer B, Tavelin B, Grönberg H.

J Urol. 2003 Apr;169(4):1345-8.

PMID:
12629357
46.

Does a low frequency of P53 and Pgp expression in familial glioma compared to sporadic controls indicate biological differences?

Malmer B, Brännström T, Andersson U, Bergh K, Grönberg H, Henriksson R.

Anticancer Res. 2002 Nov-Dec;22(6C):3949-54.

PMID:
12553017
47.

Different aetiology of familial low-grade and high-grade glioma? A nationwide cohort study of familial glioma.

Malmer B, Henriksson R, Grönberg H.

Neuroepidemiology. 2002 Nov-Dec;21(6):279-86.

PMID:
12411730
48.

Microsatellite instability, PTEN and p53 germline mutations in glioma families.

Malmer B, Grönberg H, Andersson U, Jonsson BA, Henriksson R.

Acta Oncol. 2001;40(5):633-7.

PMID:
11669337
49.

Genetic epidemiology of glioma.

Malmer B, Iselius L, Holmberg E, Collins A, Henriksson R, Grönberg H.

Br J Cancer. 2001 Feb 2;84(3):429-34.

50.

Wegener granulomatosis in children and young adults. A case study of ten patients.

Stegmayr BG, Gothefors L, Malmer B, Müller Wiefel DE, Nilsson K, Sundelin B.

Pediatr Nephrol. 2000 Mar;14(3):208-13.

PMID:
10752759

Supplemental Content

Loading ...
Support Center